The rare Arg181Cys mutation in the μ opioid receptor can abolish opioid responses

A Systematic Review of Prospective Studies Reporting Adverse Events of Commonly Used Opioids for Cancer-Related Pain: A Call for the Use of Standardized Outcome Measures

(2015) Astrid W. Oosten et al.   JOURNAL OF PAIN

Genetic and Non-genetic Factors Associated With Constipation in Cancer Patients Receiving Opioids

(2015) Eivor A Laugsand et al.   Clinical and Translational Gastroenterology

Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS study

(2014) Daniel T. Barratt et al.   Pharmacogenetics and Genomics

Assessing the response to opioids in cancer patients: a methodological proposal and the results

(2014) O. Corli et al.   SUPPORTIVE CARE IN CANCER

Opioids and their receptors: Are we there yet?

(2013) Gavril W. Pasternak   NEUROPHARMACOLOGY

µ-opioid receptor gene variantOPRM1118 A>G: a summary of its molecular and clinical consequences for pain

(2013) Carmen Walter et al.   PHARMACOGENOMICS

The N-Terminally Truncated µ3 and µ3-Like Opioid Receptors Are Transcribed from a Novel Promoter Upstream of Exon 2 in the Human OPRM1 Gene

(2013) Sonja Andersen et al.   PLoS One

Pain sensitivity and opioid analgesia: A pharmacogenomic twin study

(2012) Martin S. Angst et al.   PAIN

Influence from genetic variability on opioid use for cancer pain: A European genetic association study of 2294 cancer pain patients

(2011) P. Klepstad et al.   PAIN

Intravenous opioid dosing and outcomes in emergency patients: a prospective cohort analysis

(2010) Alec B. O'Connor et al.   AMERICAN JOURNAL OF EMERGENCY MEDICINE

Establishing “Best Practices” for Opioid Rotation: Conclusions of an Expert Panel

(2009) Perry G. Fine et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Functional characterization of human variants of the mu-opioid receptor gene

(2009) A. Ravindranathan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A Common Human μ-Opioid Receptor Genetic Variant Diminishes the Receptor Signaling Efficacy in Brain Regions Processing the Sensory Information of Pain

(2008) Bruno Georg Oertel et al.   JOURNAL OF BIOLOGICAL CHEMISTRY